Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Ambrisentan on Exercise Capacity in Fontan Patients

NCT01971580 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT01971580
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01971580 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Ambrisentan on Exercise Capacity in Fontan Patients
Lead sponsor
Washington University School of Medicine
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2012
Completion date
May 31, 2015
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

single ventricle fontan palliation